

Weight Loss · GLP-1
One of the most extensively studied GLP-1 medications for weight management, available as a weekly injection or a daily tablet. For most patients this is where treatment starts.
Physician-Prescribed Starting at
$199
Your first call with our care team is always free. If you decide to move forward, a separate medical consultation is required before any prescription can be issued.

DOCTOR-LED PROGRAMS
with expert monitoring

WEEKLY INJECTIONS
with vitamin boosters for enhanced support

REAL RESULTS
for adults struggling with obesity & slow metabolism

SAFE & NON SURGICAL
with no restrictive diets or extreme plans
Semaglutide is a GLP-1 receptor agonist—a hormone based injectable that mimics your body’s natural signals to reduce hunger, improve insulin response, and slow gastric emptying.
The result? Patients most often describe the effect as the mental chatter about food going quiet. Portions shrink without white-knuckle effort, and snacking between meals stops feeling automatic
Because the effect depends on continued dosing, semaglutide works best paired with the eating and training habits that keep results once the dose stabilises.


DUAL-HORMONE POWER
Tirzepatide targets GLP-1 and GLP-2 receptors for amplified fat-burning.

WHAT CLINICAL RESEARCH SHOWS
Adults experienced reductions of 15.0%, 19.5%, and 20.9%

ONCE-A-WEEK DOSING
Easy self-injection from home. No daily pills or drops.

REDUCED CRAVINGS
Say goodbye to food noise and mindless snacking.
PROTOCOL
A typical schedule. Yours is set by your clinician, and adjusted as you go.
| PHASE | WEEKS | TYPICAL | PURPOSE |
|---|---|---|---|
| Start | 1-4 | 0.25 mg weekly | Tolerance only. Not a weight-loss dose. |
| Step up | 5-8 | 0.5 mg weekly | First therapeutic dose for most patients. |
| Build | 9-16 | 1.0-1.7 mg weekly | Raised only if side effects are manageable. |
| Maintenance | 17+ | 1.7-2.4 mg weekly | Lowest dose that maintains steady progress. |
WHAT TO EXPECT
WEEK 1–2
Appetite softens
Meals feel bigger than they are. Mild nausea is common early.
WEEK 4–8
Visible change
Weight begins moving measurably as you reach a therapeutic dose.
MONTH 3–6
Consistent loss
The most reliable window. Protein and resistance work protect muscle.
MONTH 12+
Maintenance
Loss plateaus. Your provider sets a maintenance dose rather than stopping abruptly.

evidence
In the STEP-1 trial of Wegovy® (semaglutide 2.4 mg), adults with overweight or obesity lost an average of roughly 15% of body weight over 68 weeks, against about 2.4% on placebo.
Participants also received lifestyle counselling.
Results in practice depend heavily on whether that support is actually delivered — which is why coaching is built into this program.
Results vary. Clinical trial results apply only to the FDA-approved branded medication specifically identified and do not apply to compounded medications. All medications must be prescribed by a licensed provider based on medical necessity.
FAQ
In the STEP-1 trial of Wegovy® (Semaglutide 2.4 mg), adults lost an average of about 15% of body weight over 68 weeks. Individual results vary widely with dose, adherence, diet and activity.
Generally no. Oral Semaglutide produces smaller average weight reduction than the weekly injection, but adherence is often better for patients who will not use needles. Your provider will weigh both.
Appetite usually changes within one to two weeks of a therapeutic dose. Measurable weight change typically appears around week four to eight and continues as the dose increases.
If it has been fewer than five days, take it when you remember. If longer, skip it and resume your normal schedule. Never double up. Message your care team if you miss more than one week.
Every prescription is written by a licensed provider after a live visit and dispensed by a licensed pharmacy. Your provider prescribes only when it is clinically appropriate for you, orders bloodwork when your treatment calls for it, and reviews you on an ongoing basis.

Physician-Prescribed, Personalized Medicine for Weight, Hormones, Peptide Therapy, Metabolic Health & Longevity Across All 50 States
Contact Us
3717 E Thousand Oaks Blvd, Ste 170
Westlake Village, CA 91362
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. Compounded medications are not FDA-approved. Results may vary